Day2

Session 3

08:00 AM - 08:30 AM

Glomerular Diseases in Cancer Patients.

speaker-1

Dr. Khalid Alqarni

08:30 AM - 09:00 AM

Spectrum of GN in Saudi Arabia

speaker-1

Dr. Mohammed Alkhowaiter

09:00 AM - 09:30 AM

From Podocytopathy to Chronic Kidney Disease: The Central Role of Proteinuria.

speaker-1

Prof. Tobias Huber

09:30 AM - 10:00 AM

Coffee Break

Keynotes Lectures 2

10:00 AM - 10:30 AM

Emerging Insights into C3 Glomerulopathy: Diagnosis and Management

speaker-1

Prof. Larry Greenbaum

10:30 AM - 11:00 AM

Anti-Nephrin Podocytopathy and rFSGS Post Transplantation

speaker-1

Prof. Tobias Huber

11:00 AM - 11:30 AM

Anti-GBM Disease: Lessons from the Recommendations

speaker-1

Prof. Andreas Kronbichler

11:30 AM - 12:00 PM

DKD Management: State of the Art in 2026

speaker-1

Prof. Jürgen Floege

12:00 PM – 12:30 PM

Prayer

Luncheon Symposium 2

Hall (1) - Novartis

1- Proteinuria Under Pressure: Targeted
IgAN Therapy with Atrasentan &
Iptacopan
2- Stopping the Amplification Loop:
Iptacopan and the New Treatment
Era in C3G

speaker-1

Prof. Jürgen Floege

Session 4

01:15 PM - 01:45 PM

Pregnancy & GN: Counseling and Safe Care

speaker-1

Dr. Sarah Dahlan

01:45 PM - 02:15 PM

Case Study: C3 Glomerulopathy

speaker-1

Dr. Tofol Alnashmi

02:15 PM - 02:45 PM

Alport Syndrome

speaker-1

Prof. Larry Greenbaum

02:45 PM - 03:15 PM

Non-immunosuppression Treatment in Glomerular Disease

speaker-1

Dr. Fahad Alshehri

End of the Second Day

Contact Us
1